Global Autoimmune Disease Diagnostics Market

1
Global Autoimmune Disease Diagnostics Market
Global Autoimmune Disease Diagnostics Market
2
Global Autoimmune Disease Diagnostics Market
According to Renub Research report, tittled
Autoimmune Disease Diagnostic Market, Size.
Global Forecast 2021-2027, Industry Trends,
Impact of COVID-19, Opportunity Company Analysis
the Autoimmune Disease Diagnostics Market will be
USD 8.02 Billion by 2027. Autoimmune disorders
are a species of more than 80 chronic diseases,
out of which multiple sclerosis, Systemic Lupus
Erythematosus (SLE), rheumatoid arthritis, and
type I diabetes are the most common autoimmune
diseases. An autoimmune disease transfers to a
condition wherein the immune system destroys and
attacks healthy cells, organs of the body, and
tissues. In the longer run, it can further lead
to abnormal growth of an organ and changes in
organ function. As per Scientific American in
2021, several autoimmune diseases affect as much
as 4.5 percent of the world's population.
Further, a diagnostic of autoimmunity suspected
based on a patients symptoms, blood test results
and details of their family history. Diagnosis of
an autoimmune disease includes tests to identify
whether the body produces these autoantibodies.
Apart from this, several governing authorities
and non-governing organizations are funding
various programs to develop the autoimmune
disease diagnostic market.
Global Autoimmune Disease Diagnostics Market
3
Global Autoimmune Disease Diagnostics Market
For instance, launched by the Accelerating
Medicines Partnership (AMP), the AMP RA/SLE
Program is public-private (NIH) cooperation
between the National Institutes of Health, the US
Food and Drug Administration (FDA) and multiple
non-profit organizations. The program aims to
recognize relevant drug targets for diagnosing
autoimmune diseases. The other determinants, such
as partnerships with physici, improved laboratory
automation, clinical laboratories, and
technological advancements, encourage the
autoimmune disease diagnostics market. Hospital
professionals worldwide are focusing on adopting
advanced technologies to conduct multiple tests
with faster and more precise results. Consistent
use for Systemic and Localized Diseases Localized
autoimmune disease diagnostics segment is
further bifurcated into type 1 diabetes, multiple
sclerosis, idiopathic thrombocytopenic purpura,
Hashimoto's thyroiditis, and others. The rising
incidence of localized autoimmune diseases such
as type 1 diabetes, and multiple sclerosis and
growing patient awareness for getting tested for
these diseases opt diagnostics.
Global Autoimmune Disease Diagnostics Market
4
Global Autoimmune Disease Diagnostics Market
This can be owed to the improved adoption of
diagnostics kits and assays with consumers'
recurring incidences of autoimmune
disorders. Similarly, systemic autoimmune
disease diagnostics is characterized into
rheumatoid arthritis, ankylosing spondylitis,
systemic lupus erythematosus (SLE), and others.
Systemic autoimmune diseases are a large and
clinically diverse cluster of disorders. They
share in common inappropriate targeting of
healthy tissues by immune and inflammatory
mechanisms leading to self-injury. With technical
developments in multiple autoantibodies screening
tests to assist in the early diagnosis and
treatment of systemic autoimmune
diseases. Worldwide Autoimmune Disease
Diagnostics Market Size was US 4.94 Billion in
2021 Based on Disease, autoimmune disease
diagnostics market includes systemic Lupus
Erythematosus, Thyroiditis, Rheumatoid Arthritis,
Sjögrens Syndrome, Scleroderma and Others.
Rheumatoid arthritis disease mainly attacks the
synovial tissues within the joints.
Global Autoimmune Disease Diagnostics Market
5
Global Autoimmune Disease Diagnostics Market
The disease predominantly affects aging patients.
The old population coupled with technological
advancements in immunofluorescence and proteomics
technologies has intensified the rheumatoid
arthritis diagnosis. Off-label prescription of
NSAIDs, growing incidence of autoimmune diseases,
and other pain management drugs boost the demand
for rheumatoid arthritis diagnosis. Moreover,
thyroiditis is also known as Hashimoto's disease,
thyroid-stimulating hormone test, anti-thyroid
antibodies test, and free T4 test are the primary
tests for Hashimoto's thyroiditis. Heart
problems, myxedema, and goiter and mental health
issues are the significant complications of
thyroiditis. The rising prevalence of thyroiditis
diseases has significantly impacted the
autoimmune disease diagnostics industry. Regional
Analysis of Autoimmune Disease Diagnostics
Industry Regionally, European countries have an
enormous demand for autoimmune disease diagnosis
due to the increasing most autoimmune disorders.
As per Ms Barometer, in 2020, 1 million people
lived
Global Autoimmune Disease Diagnostics Market
6
Global Autoimmune Disease Diagnostics Market
with multiple sclerosis (MS) in Europe, and the
prevalence rate of multiple sclerosis is
increasing, especially in women than men.
Besides, the increasing awareness of auto-immune
diseases, through education, support, research,
and advocacy is a crucial part augmenting the
usage rates. The European Commission is taking
several moves to increase awareness among the
public regarding the risk factors in improving
autoimmune diseases. Consequently, as symptoms
occur, they seek diagnosis and begin a treatment
regimen. Impact of COVID-19 on Autoimmune
Disease Diagnostics Worldwide, the patients
undergoing from autoimmune disease feared the
COVID-19 had severe adverse reactions or that the
autoimmune disease may worsen amidst the
pandemic. So, certain patients could be at a
higher risk of severe COVID-19. Therefore, the
health providers working consistently for the
patients served regular autoimmune disease
diagnoses, thus helping the growth of the
diagnostic market. The leading players in the
global autoimmune disease diagnostics market are
Abbott Laboratories, Bio-Rad Laboratories, Roche
Diagnostics, Siemens Healthineers, and bioMerieux
SA.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lautoimmune-disease-diagnostic-market-p.php
Global Autoimmune Disease Diagnostics Market
7
Global Autoimmune Disease Diagnostics Market

• Market Summary
• Type We have covered Market breakup by 2
  viewpoints by-type (Systemic Autoimmune Disease
  Diagnostics and Localized Autoimmune Disease
  Diagnostics)
• Disease Renub Research Report covered by
  Disease in the 6 viewpoints (Systemic Lupus
  Erythematosus, Thyroiditis, Rheumatoid Arthritis,
  Sjögrens Syndrome, Scleroderma and Others)
• End Users Our Report covers by End Users in the
  3 viewpoints (Hospitals, Clinical Laboratories
  and Others)
• Region This Report covers Autoimmune Disease
  Diagnostic Market breakup by 5 Region (North
  America, Europe, Asia-Pacifics, Latin America
  and Middle East Africa)
• All the major players have been covered from 3
  Viewpoints (Overview, Recent Development, and
  Revenue Analysis) Abbott Laboratories, Bio-Rad
  Laboratories, Roche Diagnostics, Siemens
  Healthineers and bioMerieux SA

Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlautoimmune-disease-diagnostic-market-p.php
Global Autoimmune Disease Diagnostics Market
8
Global Autoimmune Disease Diagnostics Market
Global Autoimmune Disease Diagnostics Market
9
Contact Us
Global Autoimmune Disease Diagnostics Market